Recent Updates
Recently added Catalysts
IRWD Positive Sentiment

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call

Thursday, April 25, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Ironwood Pharmaceuticals has announced it will host an investor update call for the first quarter of 2024. This call aims to provide insights into the company's performance and future outlook. The event reflects the company's commitment to transparency and investor engagement.
Price reaction · baseline $8.1 (2024-04-24 close) · hit after-hours · clean, no other IRWD news in the window
day 0 close
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ironwood Pharmaceuticals is engaging with investors.
  • The company is focusing on transparency and communication.
  • The investor update call indicates ongoing business activity.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)

Full Press Release Details

• Company Company Overview Leadership Open Payments & Transparency
• Science & Medicine Therapeutic Focus Pipeline Product
• Patients Overview
• Responsibility Overview Diversity, Equity & Inclusion Sustainability Safety & Compliance Patients & Research Community Giving
• Careers Working at Ironwood Internships, Co-ops and Fellowships Open Positions
• Investors & Media Contact Us
• Company Overview
• Leadership
• Open Payments & Transparency
• Therapeutic Focus
• Pipeline
• Product
• Overview
• Overview
• Diversity, Equity & Inclusion
• Sustainability
• Safety & Compliance
• Patients & Research
• Community Giving
• Working at Ironwood
• Internships, Co-ops and Fellowships
• Open Positions
• Investors & Media
• Contact Us

Frequently Asked Questions

When will Ironwood host its investor update call?

Ironwood Pharmaceuticals will host its investor update call for the first quarter of 2024.

What is the purpose of the investor update call?

The call aims to provide insights into the company's performance and future outlook.

What does the investor call indicate about Ironwood?

The investor call reflects Ironwood's commitment to transparency and engagement with investors.

ShareAdd on Google
Tags: IRWD Viatris Investor Conferences Healthcare Ironwood Pharmaceuticals investor update Q1 2024 transparency financial performance
Last updated: Apr 25, 2024

Biotech snapshot

Cash runway
$79M liquidity · $0M/mo burn
Low dilution risk
Lead asset
IW-3718Phase 3
Gastroesophageal Reflux Disease (GERD) →

Catalyst track record

+57%
best trade around IRWD's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for IRWD.

See every catalyst's timing & PoA →